| May 1, 2008 Canadian Venture
Development Company Achieves Key Milestone with Completion of Successful
Commercial Pilot Program of its MPowRx Anti- Snoring Appliance.
Calgary based Tech Avenue Ventures Corp. announced today that it has
concluded a successful commercial pilot program for its clinically
proven MPowRx anti-snoring appliance in association with four dental
clinics, in Calgary, Alberta, selected for their demonstrated leadership
in adopting innovative technologies.
The response from participating clinics in the pilot program was very
positive. “We found outstanding acceptance for the MPowRx appliance from
our patients, who greatly appreciated the affordability of this new
product”, says Dr. Stephan Hrach of Kearns, Hunt & Hrach Dental Care.
“It is exciting to have an effective tool available that can be offered
to a broader patient base”, adds Dr. Hrach
The MPowRX Snoring Solution was developed by Calgary dental researcher
Dr. Leslie Dort MSc, DDS Dip ABDSM, to address the large unmet need for
a simple, economical and clinically effective over-the-counter (OTC)
solution for snoring, which impacts nearly 60 million people in North
America. A substantial number of sufferers (98%) simply ignore their
condition or seek the convenience of over-the-counter remedies that lack
clinical efficacy. More effective custom devices are available but come
at high expense and inconvenience resulting in very low adoption of
these treatment options. The MPowRX device breaks down these barriers,
giving patients an effective “first line” treatment option at an
affordable price.
The pilot dental program was designed to measure consumer acceptance,
product efficacy in a non-clinical setting and fine tune the marketing
and distribution strategy for Canada. “The pilot program has exceeded
our expectations on every level”, says Gijs van Rooijen of Tech Avenue
Ventures, “and we are accelerating plans for a full scale national
launch of the MPowRX Snoring Solution. We are thrilled that all
participating clinics will continue to offer the MPowRx appliance as
part of their dental practices”, adds van Rooijen.
Participating clinics in the MPowRx commercial pilot program in Calgary
included: Dr Larry Stanleigh Dental Clinic, Next Dimension Dentistry,
Kearns, Hunt and Hrach Dental Care and Alpha Dental Care.
MPowRx is a registered trademark of MPowRx Health and Wellness Products
Inc. More information on MPowRX Snoring Solution is available at
www.mpowrx.com
About Tech Avenue Ventures Corp
Tech Avenue Ventures Corp, incorporated in December 2005 and based in
Calgary, Alberta, is a venture development company focused on
accelerating the commercialization of high value consumer and medical
products. Tech Avenue Ventures is leveraging its life sciences
management and core expertise in the areas of sales and marketing,
research and development, manufacturing, and intellectual property to
guide the development and commercialization process and build profitable
companies. More information can be accessed at
www.taventures.ca .
Business Contact: Gijs van Rooijen, Ph.D. Co-Founder
Tech Avenue Ventures Corp.
vanro@taventures.ca
403.671.4627
|